KHC
AVNS icon

Koesten Hirschmann & Crabtree’s Avanos Medical AVNS Stock Holding History

Koesten Hirschmann & Crabtree’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-23
Closed -$286 – 273
2025
Q2 		$286 Buy
+23
New +$289 ﹤0.01% 301

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Koesten Hirschmann & Crabtree's AVNS Position: Q3 2025 in Review

Koesten Hirschmann & Crabtree sold out of Avanos Medical (AVNS) in Q3 2025, closing a stake of 23 shares — an estimated $286 sold.

Koesten Hirschmann & Crabtree first reported a position in AVNS in Q2 2025 and held it in 1 quarter. The position peaked at $286 in Q2 2025. 276 funds tracked by Wall St. Rank hold AVNS as of Q3 2025.

  • Koesten Hirschmann & Crabtree reported no remaining Avanos Medical position as of Q3 2025 after selling out during the quarter.
  • Koesten Hirschmann & Crabtree sold 23 Avanos Medical shares in Q3 2025, an estimated $286.
  • Koesten Hirschmann & Crabtree first reported a position in Avanos Medical in Q2 2025 and held it in 1 quarter.
  • Koesten Hirschmann & Crabtree's Avanos Medical position peaked at $286 in Q2 2025.
  • 276 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2025.

Based on Koesten Hirschmann & Crabtree's 13F filing for Q3 2025, filed 5 Nov 2025.